Open AccessLong-term experience with oral or inhaled vasodilator combination therapy in patients with pulmonary hypertension
Author(s) -
Sebastian Beyer
Publication year - 2006
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2006.11258
Subject(s) - medicine , bosentan , iloprost , sildenafil , combination therapy , vasodilation , pulmonary hypertension , treprostinil , cardiology , tadalafil , prostacyclin , endothelin receptor , receptor
Disease progression in pulmonary hypertension (PH) is common despite standard vasodilator monotherapy with iloprost, bosentan or sildenafil.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom